Range Low Price High Price Comment
30 days $9.59 $9.59 Wednesday, 17th Aug 2022 NLNK stock ended at $9.59. During the day the stock fluctuated 0% from a day low at $9.59 to a day high of $9.59.
90 days $9.59 $9.59
52 weeks $6.15 $11.52

Historical NewLink Genetics Corporation prices

Date Open High Low Close Volume
2022-08-17 $9.59 $9.59 $9.59 $9.59 0
2022-08-16 $9.59 $9.59 $9.59 $9.59 0
2022-08-15 $9.59 $9.59 $9.59 $9.59 0
2022-08-12 $9.59 $9.59 $9.59 $9.59 0
2022-08-11 $9.59 $9.59 $9.59 $9.59 0
2022-08-10 $9.59 $9.59 $9.59 $9.59 0
2022-08-09 $9.59 $9.59 $9.59 $9.59 0
2022-08-08 $9.59 $9.59 $9.59 $9.59 0
2022-08-05 $9.59 $9.59 $9.59 $9.59 0
2022-08-04 $9.59 $9.59 $9.59 $9.59 0
2022-08-03 $9.59 $9.59 $9.59 $9.59 0
2022-08-02 $9.59 $9.59 $9.59 $9.59 0
2022-08-01 $9.59 $9.59 $9.59 $9.59 0
2022-07-29 $9.59 $9.59 $9.59 $9.59 0
2022-07-28 $9.59 $9.59 $9.59 $9.59 0
2022-07-27 $9.59 $9.59 $9.59 $9.59 0
2022-07-26 $9.59 $9.59 $9.59 $9.59 0
2022-07-25 $9.59 $9.59 $9.59 $9.59 0
2022-07-22 $9.59 $9.59 $9.59 $9.59 0
2022-07-21 $9.59 $9.59 $9.59 $9.59 0
2022-07-20 $9.59 $9.59 $9.59 $9.59 0
2022-07-19 $9.59 $9.59 $9.59 $9.59 0
2022-07-18 $9.59 $9.59 $9.59 $9.59 0
2022-07-15 $9.59 $9.59 $9.59 $9.59 0
2022-07-14 $9.59 $9.59 $9.59 $9.59 0
Click to get the best stock tips daily for free!

About NewLink Genetics Corporation

NewLink Genetics NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. Its portfolio includes biologic product candidates based on its HyperAcute cellular immunotherapy technology, which is designed to stimulate the human immune system; and small-molecule product candidates that are focused on breaking the immune system's ... NLNK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT